THE BEST SIDE OF MBL77

Not all people with CLL have to have therapy. Despite all modern innovations, the iwCLL nevertheless endorses watchful observation for individuals with asymptomatic disease.86 This advice relies on a minimum of two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 B